Back to Authors

Johnson, Keith A.

https://orcid.org/0000-0002-5916-6043

A5090842068 | I1283280774

Mayo Clinic

for the DIAGNOSE CTE Research Project

Citations 48

Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing

Brain | February 15, 2018 | Volume: 141 | Issue: 5 | Pages: 1486-1500

10.1093/brain/awy053 | PMID 29522171

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

Neurology | July 1, 2016 | Volume: 87 | Issue: 5 | Pages: 539-547

10.1212/wnl.0000000000002923 | PMID 27371494

Massachusetts Alzheimer's Disease Research Center: Progress and challenges

Alzheimer's & Dementia | August 19, 2015 | Volume: 11 | Issue: 10 | Pages: 1241-1245

10.1016/j.jalz.2015.06.1887 | PMID 26297855

Memory, executive, and multidomain subtle cognitive impairment

Neurology | June 18, 2015 | Volume: 85 | Issue: 2 | Pages: 144-153

10.1212/wnl.0000000000001738 | PMID 26085606

Invited review: Frontotemporal dementia caused by microtubule‐associated protein tau gene ( MAPT ) mutation

Neuropathology and Applied Neurobiology | December 31, 2014 | Volume: 41 | Issue: 1 | Pages: 24-46

10.1111/nan.12213 | PMID 25556536

Hereditary frontotemporal dementia associated with mutations in the microtubule‐associated protein tau gene ( MAPT ) is a protean disorder. Three neuropathologic subtypes can be recognized, based on the presence of inclusions made of tau isoforms with three and four repeats, predominantly three repeats and mostly four repeats. This is relevant for establishing a correlation between structural magnetic resonance imaging and positron emission tomography using tracers specific for aggregated tau. Longitudinal studies will be essential to determine the evolution of anatomical alterations from the asymptomatic stage to the various phases of disease following the onset of symptoms.
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

Proceedings of the National Academy of Sciences | November 5, 2013 | Volume: 110 | Issue: 47 | Pages: No page available

10.1073/pnas.1317918110 | PMID 24194552

Significance Beta-amyloid plaque accumulation, glucose hypometabolism, and neuronal atrophy are hallmarks of Alzheimer’s disease. However, the regional ordering of these biomarkers prior to dementia remains untested. In a cohort with Alzheimer’s disease mutations, we performed an integrated whole-brain analysis of three major imaging techniques: amyloid PET, [ 18 F]fluro-deoxyglucose PET, and structural MRI. We found that most gray-matter structures with amyloid plaques later have hypometabolism followed by atrophy. Critically, however, not all regions lose metabolic function, and not all regions atrophy, even when there is significant amyloid deposition. These regional disparities have important implications for clinical trials of disease-modifying therapies.
O4–03–03: Disrupted functional connectivity in autosomal dominant Alzheimer's disease demonstrates network specificity and precedes brain volume loss: Findings from the Dominantly Inherited Alzheimer Network

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2013.04.348

IC‐P‐082: Disrupted functional connectivity in autosomal dominant Alzheimer's disease demonstrates network specificity and precedes brain volume loss: Findings from DIAN

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2013.05.079

Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases

Neurology | July 27, 2012 | Volume: 79 | Issue: 9 | Pages: 878-882

10.1212/wnl.0b013e3182661d14 | PMID 22843265

IC‐P‐138: Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2012.05.172